<DOC>
	<DOCNO>NCT01902342</DOCNO>
	<brief_summary>Investigate genetic variability CES1 gene pharmacokinetics oseltamivir healthy Korean volunteer .</brief_summary>
	<brief_title>A Clinical Trial Investigate Influence CES1 Polymorphism Oseltamivir</brief_title>
	<detailed_description />
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>Healthy subject : 1 . Agreement write informed consent 2 . Adult healthy male female subject age 20 45 1 . Clinically significant , active gastrointestinal system , cardiovascular system , pulmonary system , renal system , endocrine system , blood system , digestive system , central nervous system , mental disease malignancy 2 . Medication drug may affect pharmacokinetics oseltamivir within 14 day 3 . Previously donate whole blood within 30 day Previously participate trial within 60 day 4 . Subject know hypersensitivity reaction oseltamivir 5 . Subject perform contraception study period 6 . Female woman pregnant breast feed 7 . An impossible one participate clinical trial investigator 's decision include laboratory test result</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>